US 10954198
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases
granted A61KA61K31/155A61K31/165
Quick answer
US patent 10954198 (Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases) held by United Kingdom Research and Innovation expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Kingdom Research and Innovation
- Grant date
- Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/155, A61K31/165, A61K31/216, A61K31/44